Literature DB >> 9893343

Vascular endothelial growth factor: molecular and biological aspects.

N Ferrara1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9893343     DOI: 10.1007/978-3-642-59953-8_1

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  114 in total

Review 1.  Angiogenic signal during cardiac repair.

Authors:  Nilanjana Maulik
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

2.  In vivo correlation of tumor blood volume and permeability with histologic and molecular angiogenic markers in gliomas.

Authors:  R Jain; J Gutierrez; J Narang; L Scarpace; L R Schultz; N Lemke; S C Patel; T Mikkelsen; J P Rock
Journal:  AJNR Am J Neuroradiol       Date:  2010-11-11       Impact factor: 3.825

3.  Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.

Authors:  Przemyslaw Twardowski; Walter M Stadler; Paul Frankel; Primo N Lara; Christopher Ruel; Gurkamal Chatta; Elisabeth Heath; David I Quinn; David R Gandara
Journal:  Urology       Date:  2010-06-19       Impact factor: 2.649

4.  ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.

Authors:  Sonali Ghosh; Moitri Basu; Sib Sankar Roy
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

Review 5.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

Review 6.  Angiomyogenesis for myocardial repair.

Authors:  Husnain Kh Haider; Syed Ali Akbar; Muhammad Ashraf
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models.

Authors:  Choong Mo Kang; Sung-Min Kim; Hyun-Jung Koo; Min Su Yim; Kyung-Han Lee; Eun Kyoung Ryu; Yearn Seong Choe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-25       Impact factor: 9.236

8.  VEGF-Trap: a VEGF blocker with potent antitumor effects.

Authors:  Jocelyn Holash; Sam Davis; Nick Papadopoulos; Susan D Croll; Lillian Ho; Michelle Russell; Patricia Boland; Ray Leidich; Donna Hylton; Elena Burova; Ella Ioffe; Tammy Huang; Czeslaw Radziejewski; Kevin Bailey; James P Fandl; Tom Daly; Stanley J Wiegand; George D Yancopoulos; John S Rudge
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

9.  Cancer gene therapy with iCaspase-9 transcriptionally targeted to tumor endothelial cells.

Authors:  W Song; Z Dong; T Jin; M G Mantellini; G Núñez; J E Nör
Journal:  Cancer Gene Ther       Date:  2008-06-20       Impact factor: 5.987

10.  Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.

Authors:  Wei Li; Ru-Jun Xu; Zhen-Yun Lin; Guang-Chao Zhuo; Hong-He Zhang
Journal:  Med Oncol       Date:  2008-11-06       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.